The Recall Desk
ModerateFDA (Devices)·Z-0393-2017·Announced 2016-11-16

Baylis Medical Recalls NRG Transseptal Needles Due to Packaging Defect

Baylis Medical Corp is voluntarily recalling NRG Transseptal Needles and RF Kits because the Tyvek packaging pouches may have integrity defects.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: The recall is classified as FDA Class II and is a voluntary precautionary measure regarding a packaging integrity defect, with no reported injuries or illnesses.

Plain-English summary

Baylis Medical Corp is voluntarily recalling specific lots of the NRG Transseptal Needle and NRG RF Transseptal Kit. The recall is due to the possibility of an integrity defect in the Tyvek pouch used to package the NRG Transseptal Needle.

The affected products include various model and catalogue numbers, such as NRG-56-32-C0, NRG-71-C0, and NRG-98-C0. A total of 28,093 units are involved in this recall. The products were distributed worldwide, including in the US, Canada, Chile, France, Germany, Hong Kong, Ireland, Italy, Mexico, Netherlands, Spain, UAE, and UK.

The NRG Transseptal Needle is used to create an atrial septal defect in the heart. Users should check their inventory against the list of affected lot numbers provided in the official recall notice. If the product is found, it should be removed from use and returned to the manufacturer or a designated distributor.

The recalled product

Product
NRG Transseptal Needle and NRG RF Transseptal Kit. Model/Catalogue Numbers: NRG-56-32-C0, NRG-71-C0, NRG-71-C1, NRG-89-C0, NRG-89-C1, NRG-98-C0, NRG-98-C1, NRG-98-C1-T, NRG-E-56-32-C0, and NRG-E-HF-71-C0. The NRG Transseptal Needle is packaged onto a thermoformed tray with
Affected units
28,093

Distribution

Distribution scope not specified by the agency.